Delivery Order SPE2DB22D2206-SPE2DB26FDQ82
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $6,165.34 by the Defense Logistics Agency's Medical Supply Chain to supply Benlysta 200 mg/ml auto-injector units. The contract is non-competitive, firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and represents performance at the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,330.68 for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Benlysta 200 mg/ml auto-injector units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $6,165.34 and an ultimate completion date of June 24, 2025. The contract is non-set-aside and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $55,488.06 for Benlysta 200 mg/ml auto-injectors on September 17, 2025, with an ultimate completion date of October 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $9,248.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector units, with a completion date of August 19, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- The Defense Logistics Agency awarded a $12,330.68 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector pharmaceutical supply. The contract, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,248.01 on July 21, 2025, for the supply of Benlysta 200 mg/ml auto-injectors under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain. The contract, which carries no set-aside designation, indicates competitively awarded procurement and is scheduled for completion by August 11, 2025. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp was awarded a $6,165.34 delivery order on September 18, 2025, for the supply of Benlysta 200 mg/mL auto-injector units to support federal medical procurement needs. This firm fixed-price, competitively awarded contract is funded by the Defense Logistics Agency's Medical Supply Chain and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 9, 2025. The award represents a child order under...
- The Defense Logistics Agency awarded a $6,165.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector units. The contract, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, represents a non-set-aside competitive award. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector, with an ultimate completion date of October 16, 2025. This non-competitive, firm fixed-price delivery order represents a single purchase of this biologic medication used primarily in the treatment of systemic lupus erythematosus. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDQ82Delivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for $6,165.36 to supply Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of November 6, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Benlysta (belimumab), a monoclonal antibody used for treating systemic lupus erythematosus, falls within the specialty medication portfolio covered under this agreement. Through this contract vehicle, AmerisourceBergen supplies critical medical commodities including brand-name and generic drugs, vaccines, and medical devices to customers including the Defense Health Agency and U.S. Coast Guard. The Defense Logistics Agency's Medical Supply Chain relies on AmerisourceBergen's capabilities to fulfill federal medical procurement requirements across multiple therapeutic domains in support of military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 10/16/25 |